Spots Global Cancer Trial Database for metastatic squamous cell carcinoma
Every month we try and update this database with for metastatic squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas | NCT03283605 | Head and Neck S... Metastatic Squa... | SBRT Durvalumab Tremelimumab | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer | NCT03847519 | Lung Cancer, No... Metastatic Squa... Metastatic Non-... | ADXS-503 Pembrolizumab | 18 Years - | Advaxis, Inc. | |
| ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck | NCT06357858 | Recurrent Squam... Metastatic Squa... Head and Neck S... | INQOVI (decitab... Nivolumab | 19 Years - | Case Comprehensive Cancer Center | |
| Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas | NCT03283605 | Head and Neck S... Metastatic Squa... | SBRT Durvalumab Tremelimumab | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients | NCT04858269 | Head Neck Cance... Metastatic Squa... Oral Cavity Squ... Oropharynx Squa... Hypopharynx Squ... Larynx Squamous... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | Wake Forest University Health Sciences | |
| TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC | NCT06236425 | Squamous Cell C... Metastatic Squa... | TBio-4101 Pembrolizumab Platinum based ... Cyclophosphamid... Fludarabine Aldesleukin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC | NCT06236425 | Squamous Cell C... Metastatic Squa... | TBio-4101 Pembrolizumab Platinum based ... Cyclophosphamid... Fludarabine Aldesleukin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma | NCT05783921 | Recurrent Squam... Metastatic Squa... | TQB2618 injecti... Penpulimab inje... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma | NCT03381183 | Squamous Cell C... Squamous Cell C... Metastatic Squa... Oral Cavity Squ... Oropharynx Squa... Paranasal Sinus... Hypopharynx Squ... Larynx Squamous... | Durvalumab IRX-2 Regimen | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients | NCT04858269 | Head Neck Cance... Metastatic Squa... Oral Cavity Squ... Oropharynx Squa... Hypopharynx Squ... Larynx Squamous... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | Wake Forest University Health Sciences | |
| Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma | NCT04894370 | Squamous Cell A... Metastatic Squa... | Sample collecti... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma | NCT03381183 | Squamous Cell C... Squamous Cell C... Metastatic Squa... Oral Cavity Squ... Oropharynx Squa... Paranasal Sinus... Hypopharynx Squ... Larynx Squamous... | Durvalumab IRX-2 Regimen | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck | NCT06357858 | Recurrent Squam... Metastatic Squa... Head and Neck S... | INQOVI (decitab... Nivolumab | 19 Years - | Case Comprehensive Cancer Center | |
| First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients | NCT04858269 | Head Neck Cance... Metastatic Squa... Oral Cavity Squ... Oropharynx Squa... Hypopharynx Squ... Larynx Squamous... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | Wake Forest University Health Sciences | |
| Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma | NCT04894370 | Squamous Cell A... Metastatic Squa... | Sample collecti... | 18 Years - | Centre Hospitalier Universitaire de Besancon |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
